Half-year report · HY
4323.TEDINET S100X1TJ
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥29.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥672m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥677m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥22.8bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥22.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥20.0bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.6bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥8.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.2bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.1bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥588m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥42m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥433m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥754m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥599m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥588m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥44.77 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.24 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.38 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 66.3% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥52m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥52m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥1.1bn |
| Global Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥984m |
| Global Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥942m |
| Global Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥42m |
| Global Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥220m |
| Medical Big Data Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| Medical Big Data Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥3m |
| Medical Big Data Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥194m |
| Package Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.3bn |
| Package Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.3bn |
| Package Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥15.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥14.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥48m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥48m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥977m |
| Global Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Global Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Global Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Global Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥51m |
| Medical Big Data Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Medical Big Data Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥104,000 |
| Medical Big Data Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥77m |
| Package Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Package Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Package Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1m |
| Package Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥641m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥48m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥2.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 552
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1132962000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05236-000GlobalBusinessReportableSegmentMember | 1345436000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 13308276000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -47616000 | JPY |
| Net sales | Prior1InterimDuration | 13260660000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05236-000DXAndSIBusinessMember | 1355416000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05236-000PackageBusinessReportableSegmentMember | 641194000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 77417000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05236-000GlobalBusinessReportableSegmentMember | -51423000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 2022604000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -976926000 | JPY |
| Operating income | Prior1InterimDuration | 1045678000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05236-000DXAndSIBusinessMember | 9437176000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05236-000PackageBusinessReportableSegmentMember | 3300889000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1248662000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05236-000GlobalBusinessReportableSegmentMember | 942429000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 14929157000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 14929157000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05236-000DXAndSIBusinessMember | 7445000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05236-000PackageBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 2801000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05236-000GlobalBusinessReportableSegmentMember | 41711000 | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 51958000 | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -51958000 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05236-000DXAndSIBusinessMember | 9444622000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05236-000PackageBusinessReportableSegmentMember | 3300889000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1251463000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05236-000GlobalBusinessReportableSegmentMember | 984141000 | JPY |
| Net sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 14981116000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | -51958000 | JPY |
| Net sales | InterimDuration | 14929157000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05236-000DXAndSIBusinessMember | 1665576000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05236-000PackageBusinessReportableSegmentMember | 1121307000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 194127000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05236-000GlobalBusinessReportableSegmentMember | -219890000 | JPY |
| Operating income | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 2761120000 | JPY |
| Operating income | InterimDuration_ReconcilingItemsMember | -1067960000 | JPY |
| Operating income | InterimDuration | 1693160000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-13 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第54期中(自 2025年４月１日 至 2025年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)日本システム技術株式会社 | |
| Company name in english cover page | FilingDateInstant | Japan System Techniques Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長執行役員 平林 卓 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪市北区中之島二丁目３番18号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０６(４５６０)１０００(代) |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |